Macular Degeneration News & Updates
- FDA Approves New Treatment for Dry Eye Disease
May 30, 2025 — The FDA has approved Tryptyr (acoltremon) as the first TRPM8-targeting eye drop for dry eye disease, stimulating natural tear production as early as day one.
- New Therapy Brings Hope for Dry AMD Vision Loss
January 7, 2025 — The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.
- Antioxidant Combo May Slow Vision Loss in Advanced Macular Degeneration
August 28, 2024 — A supplement of antioxidant vitamins and minerals may slow the progression of dry age-related macular degeneration.
- Age-Related Macular Degeneration: Putting a Hole in Our World
May 10, 2024 — Estimates show that by 2040, age-related macular degeneration may affect nearly 300 million people worldwide. And we are very limited in our ability to treat or prevent it. Here's what to know.
- Metformin May Lower the Risk of Some Macular Degeneration
January 24, 2024 — The study, published in the February issue of the journal Retina, found that people who take metformin have a 5% lower risk of developing the eye disorder.
- Gene Associated With Vision Loss Also Linked to COVID: Study
January 5, 2023 — Researchers have found a genetic link between the risk for COVID-19 infection and the leading cause of vision loss among people age 50 and older, called age-related macular degeneration.
